<?xml version='1.0' encoding='utf-8'?>

<rss version="2.0">
  <channel>
    <title>The Federal Register</title>
    <link>http://thefederalregister.com/b.p/agency/Drug_Enforcement_Administration/2003-11-25/</link>
    <description>Daily Publications of Meetings and Rules Changes for the Federal Government</description>
    <pubDate>Thu, Dec 4 2008 11:00:00 GMT</pubDate>
    <lastBuildDate>Thu, Dec 4 2008 11:00:00 GMT</lastBuildDate>
    <webMaster>info@thefederalregister.com</webMaster>
    <item>
  <title><![CDATA[  Chemical Registration Waivers; Exemption From Chemical  Registration Fees for Certain Persons]]></title>
  <link>http://thefederalregister.com/d.p/2003-11-25-03-29236</link>
  <description><![CDATA[ DEA is proposing amending its regulations to waive the 
requirement of registration for contract processors, medical/first aid 
kit providers, distributors of sample packages of drug products, and 
distributors of research/reference standards pursuant to 21 U.S.C. 
822(d). These actions are being taken in response to industry comments 
and suggestions. DEA has determined that requiring registration for 
these activities is not necessary for effective enforcement under the 
Controlled Substances Act (CSA), and waiving the requirement of 
registration will ease regulatory burdens for the affected industries. 
DEA is also proposing exempting charitable organizations and 
governmental entities from initial and renewal registration fees. These 
fee exemptions will bring the chemical regulations into conformance 
with the controlled substances regulations (21 CFR 1301.21).
<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2003-11-25-03-29236</guid>
  <pubDate>Tue, Nov 25 2003 11:00:00 GMT</pubDate>
</item>
<item>
  <title><![CDATA[  Recordkeeping and Reporting Requirements for Drug Products  Containing Gamma-Hydroxybutyric Acid (GHB)]]></title>
  <link>http://thefederalregister.com/d.p/2003-11-25-03-29336</link>
  <description><![CDATA[ DEA proposes to amend its regulations to require additional 
recordkeeping and reporting requirements for drug products containing 
gammahydroxybutyric acid (GHB) for which an application has been 
approved under the Federal Food, Drug, and Cosmetic Act. DEA proposes [[Page 66049]]<br/>
these changes pursuant to section 4 of the ``Hillory J. Farias and 
Samantha Reid DateRape Drug Prohibition Act of 2000.'' These 
additional requirements are necessary to protect against the diversion 
of GHB for illicit purposes.
<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2003-11-25-03-29336</guid>
  <pubDate>Tue, Nov 25 2003 11:00:00 GMT</pubDate>
</item>
</channel>
</rss>

